Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Deferred Revenues

Deferred Revenues

9 Months Ended

Sep. 30, 2015

4. Deferred Revenues

In connection with our medical device sales and research services, we often receive cash payments before our earnings process is complete. In these instances, we record the payments as customer deposits until a device is shipped to the customer, or as customer advances in the case of research services until the earnings process is achieved. In both cases, the cash received is recorded as a component of deferred revenue.

Revenue from our Ekso medical device sales is deferred and recognized over the maintenance period. Accordingly, at the time of shipment to the customer the amount billed is recorded as deferred revenue. Also, at the time of shipment, the related inventory is reclassified to deferred cost of revenue where it is amortized to cost of revenue over the same period as the related revenue.

Deferred revenues and deferred cost of revenues consist of the following:

	September 30,			December 31,
	2015			2014
Customer deposits and advances	$	90		$	105
Deferred Ekso medical device revenues		5,917			5,327
Deferred service and leasing revenues		2,231			1,875
Deferred revenues		8,238			7,307
Less current portion		(3,839	)		(3,412	)
Deferred revenues, non-current	$	4,399		$	3,895
Deferred Ekso medical device costs	$	4,344		$	3,568
Less current portion		(1,920	)		(1,551	)
Deferred cost of revenue, non-current	$	2,424		$	2,017